ArticleBMC musculoskeletal disorders2026
Application of a YOLOv8-based model on lateral lumbar radiographs for screening of acute and chronic thoracolumbar fractures and osteoporosis.
Article in BMC musculoskeletal disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Enhanced YOLOv8 with Hybrid Attention Gating Block for Intertrochanteric Fracture Detection in Complex X-Ray Images.Journal of imaging informatics in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDifferentiating acute from chronic wedge-shaped thoracolumbar vertebral deformities on conventional lateral lumbar radiographs remains clinically challenging, especially when osteoporosis status also needs to be considered. This study aimed to develop and evaluate a You Only Look Once (YOLO)v8n framework for vertebral-level detection and classification of thoracolumbar fractures with osteoporosis-related stratification on lateral lumbar radiographs.
methodsWe retrospectively collected 1352 lateral lumbar radiographs from 1352 patients, with one radiograph per patient. A total of 1774 vertebral fracture segments were manually annotated. Lumbar magnetic resonance imaging (MRI) and dual-energy X-ray absorptiometry (DXA) were used as reference standards to stratify vertebral targets into three categories: acute fracture with osteoporosis, acute fracture without osteoporosis and chronic fracture with osteoporosis. The dataset was divided into training and validation subsets at the patient level. A YOLOv8n detector was trained as the primary model. To strengthen methodological rigor, additional baseline comparison experiments were conducted under the same patient-level training/validation split using YOLOv5n and Faster R-CNN. Detection performance was assessed using precision, recall, F1-score, mean average precision (mAP) 50 and mAP50-95.
resultsOn the validation set, the YOLOv8n model achieved a precision of 0.495, recall of 0.482, F1-score of 0.490, mAP50 of 0.506, and mAP50-95 of 0.397. In comparative experiments, YOLOv5n achieved a precision of 0.451, recall of 0.549, F1-score of 0.495, mAP50 of 0.494, and mAP50-95 of 0.367, whereas Faster R-CNN achieved a precision of 0.273, recall of 0.814, F1-score of 0.409, mAP50 of 0.300, and mAP50-95 of 0.217. These findings indicate that YOLOv8n provided the most balanced overall detection performance in the present dataset.
conclusionThe proposed YOLOv8n framework demonstrated preliminary feasibility for automated vertebral-level detection and classification of thoracolumbar fractures with osteoporosis-related stratification on lateral lumbar radiographs. However, given the moderate overall performance and lack of external validation, the current model should be regarded as an assistive screening tool rather than a standalone diagnostic system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.